Related references
Note: Only part of the references are listed.Targeting QseC signaling and virulence for antibiotic development
David A. Rasko et al.
SCIENCE (2008)
Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children - A randomized controlled trial
H Trachtman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Assessment in mice of the therapeutic potential of tailored, multivalent Shiga toxin carbohydrate ligands
GL Mulvey et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7
K Nishikawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Efficacy of postinfection treatment with anti-Shiga toxin (Stx) 2 humanized monoclonal antibody TMA-15 in mice lethally challenged with Stx-producing Escherichia coli
S Yamagami et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands
PI Kitov et al.
NATURE (2000)
A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humans
AW Paton et al.
NATURE MEDICINE (2000)
Share Paper
